Joel Gelernter, MD

Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience; Director, Division of Human Genetics (Psychiatry)

Research Departments & Organizations

Psychiatry: Center for the Translational Neuroscience of Alcoholism | Division of Human Genetics | Division of Molecular Psychiatry | Neurocognition, Neurocomputation, and Neurogenetics, Division of | Neuroscience Research Training Program (NRTP) | Psychotherapy Development Center | Stress & Addiction Clinical Research Program | VA Alcohol Research Center | VA-Yale Clinical Neurosciences PTSD Research Program

Global Health Studies

Office of Cooperative Research

Research Interests

Affective Disorders, Psychotic; Alcoholism; Anxiety Disorders; China; Genetics; Genetics, Population; Global Health; Israel; Polymorphism, Genetic; Psychiatry; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Thailand

Research Summary

The research focus of my laboratory is genetics of psychiatric illness. We study a range of behavioral phenotypes including opioid, cananbis, and alcohol dependence, posttraumatic stress disorder (PTSD), and anxiety disorders. In addition we study a range of intermediate phenotypes, such as neuroimaging measures; and basic issues in population and complex trait genetics.

The overall approach involves study of genetic polymorphism and sequence variation, on a molecular level, and from the perspective of population genetics. Current studies include multicenter case/control association studies with the goal of identifying genes predisposing to opioid and alcohol dependence (using genomewide association analysis and other approaches); a whole exome sequencing study of methamphetamine dependence, in Thailand; studies of posttraumatic stress disorder (PTSD) in the US Million Veteran Program; and a VA study on the pharmacogenomics of antidepressant response. I also co-lead the Substance Use Disorders group of the Psychiatric Genomics Consortium.

Specialized Terms: Complex trait genetics; Psychiatric genetics; Population genetics; Substance dependence; Pharmacogenomics

Clinical Trials

Conditions Study Title
Diseases of the Nervous System, Mental Health & Behavioral Research C4 Gene Dose Effects using 11C-UCB-J PET
Diseases of the Nervous System, Genetics - Adult, Genetics - Pediatric, Mental Health & Behavioral Research Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)
Addictive Behaviors, Alcohol Addiction, Genetics - Adult, Mental Health & Behavioral Research Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

Activities

  • Substance use disorder genetics Taipei, Taiwan (2013)

    Development of Chinese SSADDA instrument; use in studies of ketamine and opioid dependence

  • Thailand, Illicit drugs Thailand (2010)

    Thai-US Drug Dependence Genetics Research Training Grant

  • Alcohol, China China (2010)

    Alcohol Dependence Genetics in a Large Chinese Pedigree

  • Drug dependence genetics Bangkok, Thailand (2009)

    Training program

Selected Publications

See list of PubMed publications

Edit this profile

Contact Info

Joel Gelernter, MD
Mailing Address
PsychiatryVA CT Healthcare Center S116A2
950 Campbell Avenue

West Haven, CT 06516